Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.